Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Staals

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Oncologist|March 4, 2023
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment StrategiesEmanuela Palmerini, John H Healey, Nicholas M Bernthal, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitorsEmanuela Palmerini, Eric L Staals, Robert G Maki, et al.
The Journal of Bone and Joint Surgery. American Volume|January 18, 2019
Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European StudyBas C J Majoor, Michiel A J van de Sande, Natasha M Appelman-Dijkstra, et al.
Journal of Surgical Oncology|August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysisNicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Cancer|November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumorsHans Gelderblom, Andrew J Wagner, William D Tap, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 12, 2024
Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort studyGeert Spierenburg, Eric L Staals, Emanuela Palmerini, et al.
The Lancet. Oncology|April 29, 2019
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort studyMonique J L Mastboom, Emanuela Palmerini, Floortje G M Verspoor, et al.
Cancer|February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Cancer Treatment Reviews|December 11, 2022
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of expertsSilvia Stacchiotti, Hans Roland Dürr, Inga-Marie Schaefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Oncologist|March 4, 2023
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment StrategiesEmanuela Palmerini, John H Healey, Nicholas M Bernthal, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitorsEmanuela Palmerini, Eric L Staals, Robert G Maki, et al.
The Journal of Bone and Joint Surgery. American Volume|January 18, 2019
Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European StudyBas C J Majoor, Michiel A J van de Sande, Natasha M Appelman-Dijkstra, et al.
Journal of Surgical Oncology|August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysisNicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Cancer|November 16, 2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumorsHans Gelderblom, Andrew J Wagner, William D Tap, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 12, 2024
Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort studyGeert Spierenburg, Eric L Staals, Emanuela Palmerini, et al.
The Lancet. Oncology|April 29, 2019
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort studyMonique J L Mastboom, Emanuela Palmerini, Floortje G M Verspoor, et al.
Cancer|February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Cancer Treatment Reviews|December 11, 2022
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of expertsSilvia Stacchiotti, Hans Roland Dürr, Inga-Marie Schaefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
Pageof 5